Magnetic Particle Imaging-Guided Hyperthermia for Precise Treatment of Cancer: Review, Challenges, and Prospects

Overview

Journal Mol Imaging Biol

Publisher Springer

Specialties Molecular Biology
Radiology

Date 2023 Oct 3

PMID 37789103

Authors

Siao Lei

Jie He

Pengli Gao

Yueqi Wang

Hui Hui

Yu An

Jie Tian

Affiliations

Soon will be listed here.

Abstract

Magnetic particle imaging (MPI) is a novel quantitative imaging technique using the nonlinear magnetization behavior of magnetic nanoparticles (MNPs) to determine their local concentration. Magnetic fluid hyperthermia (MFH) is a promising non-invasive therapy using the heating effects of MNPs. MPI-MFH is expected to enable real-time MPI guidance, localized MFH, and non-invasive temperature monitoring, which shows great potential for precise treatment of cancer. In this review, we introduce the fundamentals of MPI and MFH and their applications in the treatment of cancer. Also, we discuss the challenges and prospects of MPI-MFH.

Citing Articles

A Compendium of Magnetic Nanoparticle Essentials: A Comprehensive Guide for Beginners and Experts.

Amorim C Pharmaceutics. 2025; 17(1).

PMID: 39861783 PMC: 11768579. DOI: 10.3390/pharmaceutics17010137.

Advances in engineering nanoparticles for magnetic particle imaging (MPI).

Velazquez-Albino A, Imhoff E, Rinaldi-Ramos C Sci Adv. 2025; 11(2):eado7356.

PMID: 39772674 PMC: 11708890. DOI: 10.1126/sciadv.ado7356.

Integrable Magnetic Fluid Hyperthermia Systems for 3D Magnetic Particle Imaging.

Behrends A, Wei H, Neumann A, Friedrich T, Bakenecker A, Franke J Nanotheranostics. 2024; 8(2):163-178.

PMID: 38444740 PMC: 10911971. DOI: 10.7150/ntno.90360.

References

Lee Y, Tan Y, Oon C . Molecular targeted therapy: Treating cancer with specificity. Eur J Pharmacol. 2018; 834:188-196. DOI: 10.1016/j.ejphar.2018.07.034. View

Matsen C, Neumayer L . Breast cancer: a review for the general surgeon. JAMA Surg. 2013; 148(10):971-9. DOI: 10.1001/jamasurg.2013.3393. View

Blumenschein G, Distefano A, Caderao J, Fristenberg B, Adams J, Schweichler L . Multimodality therapy for locally advanced and limited stage IV breast cancer: the impact of effective non-cross-resistance late-consolidation chemotherapy. Clin Cancer Res. 1999; 3(12 Pt 2):2633-7. View

Baskar R, Lee K, Yeo R, Yeoh K . Cancer and radiation therapy: current advances and future directions. Int J Med Sci. 2012; 9(3):193-9. PMC: 3298009. DOI: 10.7150/ijms.3635. View

Mohan R, Bortfeld T . Proton therapy: clinical gains through current and future treatment programs. Front Radiat Ther Oncol. 2011; 43:440-464. DOI: 10.1159/000322509. View

Dinesh Mayani D . Proton therapy for cancer treatment. J Oncol Pharm Pract. 2010; 17(3):186-90. DOI: 10.1177/1078155210375858. View

Mohan R, Grosshans D . Proton therapy - Present and future. Adv Drug Deliv Rev. 2016; 109:26-44. PMC: 5303653. DOI: 10.1016/j.addr.2016.11.006. View

Chari R . Targeted cancer therapy: conferring specificity to cytotoxic drugs. Acc Chem Res. 2007; 41(1):98-107. DOI: 10.1021/ar700108g. View

Galluzzi L, Humeau J, Buque A, Zitvogel L, Kroemer G . Immunostimulation with chemotherapy in the era of immune checkpoint inhibitors. Nat Rev Clin Oncol. 2020; 17(12):725-741. DOI: 10.1038/s41571-020-0413-z. View

10.

Farzin L, Saber R, Sadjadi S, Mohagheghpour E, Sheini A . Nanomaterials-based hyperthermia: A literature review from concept to applications in chemistry and biomedicine. J Therm Biol. 2022; 104:103201. DOI: 10.1016/j.jtherbio.2022.103201. View

11.

Harmon B, Takano Y, Winterford C, Gobe G . The role of apoptosis in the response of cells and tumours to mild hyperthermia. Int J Radiat Biol. 1991; 59(2):489-501. DOI: 10.1080/09553009114550441. View

12.

Schildkopf P, Ott O, Frey B, Wadepohl M, Sauer R, Fietkau R . Biological rationales and clinical applications of temperature controlled hyperthermia--implications for multimodal cancer treatments. Curr Med Chem. 2010; 17(27):3045-57. DOI: 10.2174/092986710791959774. View

13.

Schneider C, Woodworth G, Vujaskovic Z, Mishra M . Radiosensitization of high-grade gliomas through induced hyperthermia: Review of clinical experience and the potential role of MR-guided focused ultrasound. Radiother Oncol. 2019; 142:43-51. DOI: 10.1016/j.radonc.2019.07.017. View

14.

Roussakow S . Neo-adjuvant chemotherapy alone or with regional hyperthermia for soft-tissue sarcoma. Lancet Oncol. 2017; 18(11):e629. DOI: 10.1016/S1470-2045(17)30643-5. View

15.

Nagata Y, Hiraoka M, Nishimura Y, Masunaga S, Mitumori M, Okuno Y . Clinical results of radiofrequency hyperthermia for malignant liver tumors. Int J Radiat Oncol Biol Phys. 1997; 38(2):359-65. DOI: 10.1016/s0360-3016(96)00625-6. View

16.

Hildebrandt B, Wust P, Gellermann J, Nicolaou A, Trappe R, Felix R . Treatment of locally recurrent rectal cancer with special focus on regional pelvic hyperthermia. Onkologie. 2004; 27(5):506-11. DOI: 10.1159/000080374. View

17.

Franco J, Garegnani L, Escobar Liquitay C, Borofsky M, Dahm P . Transurethral Microwave Thermotherapy for Benign Prostatic Hyperplasia: An Updated Cochrane Review. World J Mens Health. 2021; 40(1):127-138. PMC: 8761240. DOI: 10.5534/wjmh.210115. View

18.

Wu F . High intensity focused ultrasound: a noninvasive therapy for locally advanced pancreatic cancer. World J Gastroenterol. 2014; 20(44):16480-8. PMC: 4248191. DOI: 10.3748/wjg.v20.i44.16480. View

19.

Kim Y . Clinical application of high-intensity focused ultrasound ablation for uterine fibroids. Biomed Eng Lett. 2019; 7(2):99-105. PMC: 6208477. DOI: 10.1007/s13534-017-0012-9. View

20.

Lang B, Wu A . The efficacy and safety of high-intensity focused ultrasound ablation of benign thyroid nodules. Ultrasonography. 2017; 37(2):89-97. PMC: 5885474. DOI: 10.14366/usg.17057. View